OR WAIT 15 SECS
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
What challenges do biopharmaceutical manufacturers face when deciding to move from a fed batch process to a continuous process?
What challenges do biopharmaceutical manufacturers face when deciding to move from a fed batch process to a continuous process? Stéphanie Dubois, cell culture laboratory manager and application specialist at Pall Life Sciences, describes challenges and explains how alternative types of perfusion bioreactors can simplify the process.
Download
.
Related Content:
Aseptic/Sterile Processing | Biologic Drugs | Manufacturing | Equipment | Dosage Forms | Manufacturing Equipment, Upstream Processing